Pathogenesis of prostate cancer and hormone refractory prostate cancer

por Girling, J. S., Whitaker, H. C., Mills, I. G., Neal, D. E.
Publicado 2007

Peroxiredoxin-3 is overexpressed in prostate cancer and promotes cancer cell survival by protecting cells from oxidative stress

por Whitaker, H C, Patel, D, Howat, W J, Warren, A Y, Kay, J D, Sangan, T, Marioni, J C, Mitchell, J, Aldridge, S, Luxton, H J, Massie, C, Lynch, A G, Neal, D E
Publicado 2013